Metraipolis › archive › dc_d07aac2599dd
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40817386
- DOI
- 10.1038/s41434-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T14:08:48.628Z
- SHA-256 of the archived text
ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63- Stable URL of this page
https://metraipolis.com/documento/dc_d07aac2599dd
How to cite
AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386 — Europe PMC (en), https://europepmc.org/article/MED/40817386 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d07aac2599dd (Metraipolis archive dc_d07aac2599dd, sha256 ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63)
BibTeX
@misc{dcd07aac2599dd,
title = {AAV microdystrophin gene replacement therapy for Duchenne muscular dystrophy: progress and prospects — Europe PMC PMID:40817386},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40817386},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d07aac2599dd; sha256 ec1213d5ecf3d26069e41696ffd9edbe53b05a4922d0116569c268b35a887b63},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40817386. Agents can read the archived copy with the MCP tool read_document.